BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8166046)

  • 1. Pharmacotherapy of HIV. APhA Editorial Board on Pharmaceutical Care for Patients with HIV Infection.
    Am Pharm; 1994 Feb; NS34(2):60-9; quiz 69-70. PubMed ID: 8166046
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of HIV infection with nucleoside analogs].
    Jablonowski H; Mauss S; Armbrecht C; Manegold C; Szelenyi H; Hengels KJ
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():60-6. PubMed ID: 8197806
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiretroviral therapy. Current status and perspectives].
    Lüthy R
    Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223
    [No Abstract]   [Full Text] [Related]  

  • 5. [HIV infection--current possibilities in antiviral therapy].
    Hirschel B
    Ther Umsch; 1994 Aug; 51(8):545-50. PubMed ID: 7940411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of HIV disease in 1993/1994.
    Fischl MA
    AIDS Clin Rev; 1993-1994; ():167-87. PubMed ID: 8217898
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for HIV infection.
    Med Lett Drugs Ther; 1990 Feb; 31(811):11-3. PubMed ID: 2153901
    [No Abstract]   [Full Text] [Related]  

  • 8. Intermittent therapy.
    Volberding PA
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):454-6. PubMed ID: 8158538
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-retroviral treatment. Treatment modification: toxicity management].
    Ocaña I; Laguna F; Pulido F; Bascuñana A
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():31-5. PubMed ID: 9053025
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
    Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy for human immunodeficiency virus infection -- what have we learned?
    Corey L; Holmes KK
    N Engl J Med; 1996 Oct; 335(15):1142-4. PubMed ID: 8813046
    [No Abstract]   [Full Text] [Related]  

  • 12. Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group.
    Schooley RT; Ramirez-Ronda C; Lange JM; Cooper DA; Lavelle J; Lefkowitz L; Moore M; Larder BA; St Clair M; Mulder JW; McKinnis R; Pennington KN; Harrigan PR; Kinghorn I; Steel H; Rooney JF
    J Infect Dis; 1996 Jun; 173(6):1354-66. PubMed ID: 8648207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for HIV infection.
    Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral therapy for adults and children.
    AIDS Inst Newsl; 1995 Jun; ():1-19. PubMed ID: 11367409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS.
    Saravolatz LD; Winslow DL; Collins G; Hodges JS; Pettinelli C; Stein DS; Markowitz N; Reves R; Loveless MO; Crane L; Thompson M; Abrams D
    N Engl J Med; 1996 Oct; 335(15):1099-106. PubMed ID: 8813040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy in HIV-infected adults. Which regimens are recommended?
    Lancaster DJ; Lancaster LL
    Postgrad Med; 1994 Jan; 95(1):47-50, 53-5. PubMed ID: 7904062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E
    Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
    [No Abstract]   [Full Text] [Related]  

  • 18. What we know about anti-HIV drugs.
    Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with ZDV + DDI versus ZDV + DDC in patients with progression of HIV-infection under treatment with ZDV.
    Mauss S; Adams O; Willers R; Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):469-77. PubMed ID: 8605592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of zidovudine, didanosine, zalcitabine and no antiretroviral therapy in patients with advanced HIV disease.
    Torres RA; Barr MR; McIntyre KI; Thornton JR; Shay WM; Feldman RD; George NJ; Britton DJ
    Int J STD AIDS; 1995; 6(1):19-26. PubMed ID: 7727578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.